Assessing treatment adherence is crucial to determine adequacy of mineralocorticoid therapy

Assessing treatment adherence is crucial to determine adequacy of mineralocorticoid therapy

Background: There is no consensus strategy for mineralocorticoid (MC) therapy titration in patients with primary adrenal insufficiency (PAI). W e aim to measure serum fludrocortisone (sFC) and urine fludrocortisone (uFC) levels and to determine their utility, alongside clinical/biochemical variables...

Full description

Bibliographic Details
Main Authors:	Riccardo Pofi, Ilaria Bonaventura, Joanne Duffy, Zoe Maunsell, Brian Shine, Andrea M Isidori, Jeremy W Tomlinson
Format:	Article
Language:	English
Published:	Bioscientifica 2023-08-01
Series:	Endocrine Connections
Subjects:	mineralocorticoids glucocorticoids congenital adrenal hyperplasia addison’s disease renin
Online Access:	https://ec.bioscientifica.com/view/journals/ec/12/9/EC-23-0059.xml

Similar Items

Heterogeneous natural history of Addison’s disease: mineralocorticoid deficiency may predominate
by: Sophie Howarth, et al.
Published: (2022-12-01)

Revisión de la Enfermedad de Addison en adultos.
by: Omar Banegas Peña, et al.
Published: (2021-09-01)

Primary adrenal insufficiency in adult population: a Portuguese Multicentre Study by the Adrenal Tumours Study Group
by: Lia Ferreira, et al.
Published: (2017-11-01)

Hipoadrenocorticismo primario canino: reporte de caso
by: J. L. Granados, et al.
Published: (2011-01-01)

<b>Hipoadrenocorticismo primario canino: reporte de caso</b>
by: <i>J. L. Granados</i>, et al.
Published: (2011-06-01)

Real-World Effectiveness of Mineralocorticoid Receptor Antagonists in Primary Aldosteronism
by: Yuta Tezuka, et al.
Published: (2021-03-01)

A Contemporary Approach to the Diagnosis and Management of Adrenal Insufficiency
by: Suranut Charoensri, et al.
Published: (2024-02-01)

Bilateral Adrenal Masses with Different Aetiologies Presenting as Addisonian Crisis with Acute Kidney Injury: A Case Series
by: Mohini, et al.
Published: (2023-11-01)

Editorial: Adrenal neuroendocrine system and cardiometabolic health: pathophysiology and clinical implications
by: Moe Thuzar, et al.
Published: (2023-10-01)

Clinical features and long‐term management of cats with primary hypoadrenocorticism using desoxycorticosterone pivalate and prednisolone
by: Nadja S. Sieber‐Ruckstuhl, et al.
Published: (2023-03-01)

Combinatorial actions of glucocorticoid and mineralocorticoid stress hormone receptors are required for preventing neurodegeneration of the mouse hippocampus
by: Robert H. Oakley, et al.
Published: (2021-11-01)

Apparent mineralocorticoid excess - A rare cause of endocrine hypertension
by: Sonali Verma, et al.
Published: (2022-01-01)

Novel Insights into the Role of the Mineralocorticoid Receptor in Human Glioblastoma
by: Paula Aldaz, et al.
Published: (2021-10-01)

Chronic Systemic Dexamethasone Regulates the Mineralocorticoid/Glucocorticoid Pathways Balance in Rat Ocular Tissues
by: Marta Zola, et al.
Published: (2022-01-01)

EVOLUTION STAGES OF LOW RENIN HYPERTENSION
by: S. V. Akhadov, et al.
Published: (2016-01-01)

Disruption of Glucocorticoid and Mineralocorticoid Receptor-Mediated Responses by Environmental Chemicals
by: Alex Odermatt, et al.
Published: (2008-05-01)

Expression of genes encoding mineralocorticoid biosynthetic enzymes and the mineralocorticoid receptor, and levels of mineralocorticoids in the bovine follicle and corpus luteum
by: Memory MUKANGWA, et al.
Published: (2019-12-01)

Mineralocorticoid Receptor Antagonists Eplerenone and Spironolactone Modify Adrenal Cortex Morphology and Physiology
by: Sofia S. Pereira, et al.
Published: (2021-04-01)

11-Deoxycorticosterone Producing Adrenal Hyperplasia as a Very Unusual Cause of Endocrine Hypertension: Case Report and Systematic Review of the Literature
by: Queralt Asla, et al.
Published: (2022-03-01)

Classic and current concepts in adrenal steroidogenesis: a reappraisal
by: Claudio E. Kater, et al.
Published: (2022-03-01)

Mineralocorticoid receptor and glucocorticoid receptor work alone and together in cell-type-specific manner: Implications for resilience prediction and targeted therapy
by: Nikolaos P. Daskalakis, et al.
Published: (2022-05-01)

Characterization of clinicopathologic and abdominal ultrasound findings in dogs with glucocorticoid deficient hypoadrenocorticism
by: Krystle L. Reagan, et al.
Published: (2022-11-01)

Major immunophenotypic abnormalities in patients with primary adrenal insufficiency of different etiology
by: Hanna F. Nowotny, et al.
Published: (2023-11-01)

Low‐dose desoxycorticosterone pivalate treatment of hypoadrenocorticism in dogs: A randomized controlled clinical trial
by: Alysha M. Vincent, et al.
Published: (2021-07-01)

Dichlorodiphenyltrichloroethane and the Adrenal Gland: From Toxicity to Endocrine Disruption
by: Ekaterina P. Timokhina, et al.
Published: (2021-10-01)

A Case of Adrenal Tuberculosis with Atypical Clinical Manifestation
by: Moo Hyun Son, et al.
Published: (2013-12-01)

Patient journey experiences may contribute to improve healthcare for patients with rare endocrine diseases
by: Susan M Webb, et al.
Published: (2022-11-01)

Translation of Experimental Findings from Animal to Human Biology: Identification of Neuronal Mineralocorticoid and Glucocorticoid Receptors in a Sectioned Main Nerve Trunk of the Leg
by: Sascha Tafelski, et al.
Published: (2023-07-01)

Imbalanced glucocorticoid and mineralocorticoid stress hormone receptor function has sex-dependent and independent regulatory effects in the mouse hippocampus
by: Robert H. Oakley, et al.
Published: (2024-01-01)

Role of glucocorticoid and mineralocorticoid receptors in rainbow trout (Oncorhynchus mykiss) skeletal muscle: A transcriptomic perspective of cortisol action
by: Jorge E. Aedo, et al.
Published: (2023-01-01)

SEVERE METABOLIC DISORDER – CAUSE OF DEATH AT A NEWBORN SUFFERING FROM CHRONIC CONDITION
by: Roxana Tanase, et al.
Published: (2017-12-01)

Course of COVID-19 infection in patients with congenital adrenal hyperplasia
by: Rida Javaid, et al.
Published: (2024-02-01)

Behavioral stress induces regionally-distinct shifts of brain mineralocorticoid and glucocorticoid receptor levels
by: Dorian eCaudal, et al.
Published: (2014-01-01)

The Dual Dose-Dependent Effects of Corticosterone on Hippocampal Cell Apoptosis After Traumatic Brain Injury Depend on the Activation Ratio of Mineralocorticoid Receptors to Glucocorticoid Receptors
by: Bin Zhang, et al.
Published: (2021-07-01)

Pilot study shows suppression of mineralocorticoid precursors under high-dose glucocorticoid therapy in pediatric acute lymphoblastic leukemia
by: Paul-Martin Holterhus, et al.
Published: (2023-09-01)

Diagnosis of canine spontaneous hypoadrenocorticism
by: Pedro J. Guzmán Ramos, et al.
Published: (2022-05-01)

Addison’s disease associated to paracocidioidomycosis
by: Claudio Maranhão Pereira, et al.
Published: (2015-11-01)

Disorders of Sex Development of Adrenal Origin
by: Gabriela P. Finkielstain, et al.
Published: (2021-12-01)

Mineralocorticoid Antagonist Improves Glucocorticoid Receptor Signaling and Dexamethasone Analgesia in an Animal Model of Low Back Pain
by: Shaimaa I. A. Ibrahim, et al.
Published: (2018-11-01)

Hipoadrenocorticismo primário em um cão Primary hipoadrenocorticism in a dog
by: Mauren Picada Emanuelli, et al.
Published: (2007-10-01)